Skip to main content
. 2019 May 14;14(10):1343–1365. doi: 10.2217/nnm-2018-0347

Figure 6. . The application of functional metal-organic framework nanocompositions for theranostics.

Figure 6. 

(A) Illustration of pH-responsive FCZ nanoparticles as drug delivery vehicles. (B) Subcellular localization of the FCZ nanoparticles by transfected HeLa cells with mecherry-LAMP-1. (C) T2*-weighted images of A549 cells with FCZ nanoparticles untreated and treated at different concentrations. (D) In vivo antitumor efficacy of DOX-loaded FCZ nanoparticles in the A549 lung cancer mice model tumor. (E) Scheme of the synthesis of DOX-loaded Fe3O4@UiO-66 core–shell nanoparticles for imaging and therapy. (F) T2-weighted MRI images and transverse relativity of Fe3O4@UiO-66 at different Fe concentrations. (G) Tumor biopsies from the PBS and Fe3O4@UiO-66-DOX-treated mice on day 30. (H) MRI images of HeLa tumor-bearing mice treated by PBS and Fe3O4@UiO-66-DOX at different times. (I) Transmission electron microscopy image of the core–shell AuNR@ZIF-8 nanostructures, bottom: HAADF-STEM image and energy-dispersive X-ray spectroscopy elemental mapping of single AuNR@ZIF-8 core–shell nanoparticle. (J) DOX release profiles from the AuNR@ZIF-8-DOX nanostructures with and without 808-nm laser irradiation (1 w/cm2) at different pH values. (K) Relative tumor volume from 4T1 tumor-bearing mice with different types of treatments.

DOX: Doxorubicin; FCZ: Fe3O4@C@ZIF-8; PBS: Phosphate-buffered saline; TEM: Transmission electron microscopy; UiO: Universitetet i Oslo; ZIF-8: Zeolitic imidazolate framework-8.

(A) Reproduced with permission from [92] © Royal Society of Chemistry (2015).

(B) Reproduced with permission from [92] © Royal Society of Chemistry (2015).

(C) Reproduced with permission from [92] © Royal Society of Chemistry (2015).

(D) Reproduced with permission from [92] © Royal Society of Chemistry (2015).

(E) Reproduced with permission from [93] © Royal Society of Chemistry licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported Licence (2016).

(F) Reproduced with permission from [93] © Royal Society of Chemistry licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported Licence (2016).

(G) Reproduced with permission from [93] © Royal Society of Chemistry licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported Licence (2016).

(H) Reproduced with permission from [93] © Royal Society of Chemistry licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported Licence (2016).

(I) Reproduced with permission from [94] © Tsinghua University Press and Springer-Verlag GmbH Germany, part of Springer Nature (2017).

(J) Reproduced with permission from [94] © Tsinghua University Press and Springer-Verlag GmbH Germany, part of Springer Nature (2017).

(K) Reproduced with permission from [94] © Tsinghua University Press and Springer-Verlag GmbH Germany, part of Springer Nature (2017).

For further permissions, please contact Royal Society of Chemistry: http://www.rsc.org/journals-books-databases/journal-authors-reviewers/licences-copyright-permissions/#deposition-sharing.